{"id":"W3091839086","doi":"10.1093/ibd/izaa265","title":"Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice","year":2020,"lang":"en","type":"review","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Infliximab; Therapeutic drug monitoring; Adalimumab; Vedolizumab; Crohn's disease; Tumor necrosis factor alpha; Internal medicine; Inflammatory bowel disease; Pharmacokinetics; Pharmacology; Intensive care medicine; Disease; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004041594,0.0007870226,0.001584698,0.002642612,0.0003289209,0.00193383,0.001485697,0.002493119,0.001965611],"category_scores_gemma":[0.006492048,0.0003239645,0.0009319262,0.002385383,0.001443049,0.003050579,0.001098675,0.00472611,0.001288533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001769331,"about_ca_system_score_gemma":0.00379915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001638272,"about_ca_topic_score_gemma":0.001800902,"domain_scores_codex":[0.9980655,0.000804771,0.0003161703,0.0001809263,0.000569685,0.00006302528],"domain_scores_gemma":[0.9966182,0.002215446,0.0003247436,0.00009225071,0.0006437678,0.0001056615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.00006052784,0.00006289712,0.0002219894,0.02126348,0.0001355305,0.000129472,0.0001557794,0.0006465163,0.0004377842,0.02785541,0.04663135,0.9023993],"study_design_scores_gemma":[0.00003686063,0.00009106855,0.00068554,0.02267308,0.0001553164,0.0008648332,0.0001078759,0.0002918054,0.0001514226,0.01427417,0.9606401,0.00002807505],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007491796,0.9926212,0.0009538067,0.003912336,0.0006674542,0.00001720364,0.00002356629,0.00001598122,0.001713541],"genre_scores_gemma":[0.001303235,0.9931062,0.001985877,0.002312915,0.0007149177,0.00003834469,0.00004002902,0.000005206347,0.0004933094],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004041594,"threshold_uncertainty_score":0.02137429,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.033852874655146,"score_gpt":0.3806763246289317,"score_spread":0.3468234499737857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}